Tower Research Capital (TRC)’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $59.4K | Sell |
|
|||||
|
2025
Q2 | $113K | Buy |
|
|||||
|
2025
Q1 | $18K | Sell |
|
|||||
|
2024
Q4 | $85.5K | Sell |
|
|||||
|
2024
Q3 | $365K | Buy |
|
|||||
|
2024
Q2 | $125K | Buy |
|
|||||
|
2024
Q1 | $7.74K | Sell |
|
|||||
|
2023
Q4 | $248K | Buy |
|
|||||
|
2023
Q3 | $16.6K | Sell |
|
|||||
|
2023
Q2 | $22.1K | Sell |
|
|||||
|
2023
Q1 | $21K | Buy |
|
|||||
|
2022
Q4 | $12K | Sell |
|
|||||
|
2022
Q3 | $91K | Buy |
|
|||||
|
2022
Q2 | $13K | Buy |
|
|||||
|
2022
Q1 | $6K | Sell |
|
|||||
|
2021
Q4 | $13K | Sell |
|
|||||
|
2021
Q3 | $31K | Sell |
|
|||||
|
2021
Q2 | $58K | Buy |
|
|||||
|
2021
Q1 | $19K | Sell |
|
|||||
|
2020
Q4 | $31K | Sell |
|
|||||
|
2020
Q3 | $246K | Buy |
|
|||||
|
2020
Q2 | $51K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $32K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $11K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $27K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $30K | Buy |
|
|||||
|
2016
Q4 | $5K | Sell |
|
|||||
|
2016
Q3 | $55K | Buy |
|
|||||
|
2016
Q2 | $13K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $108K | Buy |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Hold |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $183K | Buy |
|
|||||
|
2014
Q1 | $64K | Buy |
|
|||||
|
2013
Q4 | $2K | Buy |
|
|||||
|
2013
Q3 | $1K | Sell |
|
|||||
|
2013
Q2 | $5K | Buy |
|